PAPER Vacirca D, Barbati C, Scazzocchio B, Masella R, Rosano G, Malorni W, Ortona E
SEARCH RESULTS
329963 RESULTS
PAPER Zhang L, Fang Y, Zeng Z, Lian Y, Wei J, Zhu H, Jia Y, Zhao X, Xu Y
BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response.
J Alzheimers Dis. 2011;26(3):523-30. PubMed: 21677379PAPER Karakas E, Simorowski N, Furukawa H
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Nature. 2011 Jul 14;475(7355):249-53. PubMed: 21677647PAPER Valls-Pedret C, Olives J, Bosch B, Caprile C, Castellví M, Molinuevo JL, Rami L
[Landscape test for assessing visual memory in Alzheimer's disease].
Rev Neurol. 2011 Jul 1;53(1):1-7. PubMed: 21678318PAPER Akram A, Schmeidler J, Katsel P, Hof PR, Haroutunian V
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
Neurobiol Aging. 2012 Mar;33(3):628.e1-628.e14. PubMed: 21676498PAPER Ponomareva EV
[Depressions in Alzheimer's disease].
Vestn Ross Akad Med Nauk. 2011;(4):38-44. PubMed: 21674921PAPER Hinton L
Facing the 'Alzheimer-ed subject'.
J Anal Psychol. 2011 Jun;56(3):381-5. PubMed: 21675984PAPER Grammas P, Martinez J, Miller B
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
Expert Rev Mol Med. 2011;13:e19. PubMed: 21676288PAPER Manso Y, Adlard PA, Carrasco J, Vašák M, Hidalgo J
Metallothionein and brain inflammation.
J Biol Inorg Chem. 2011 Oct;16(7):1103-13. PubMed: 21678079Susanne Aileen Funke on Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation.
COMMENT Small molecule ligands rationally designed to complement β-sheet hydrogen-bond patterns present in fibrils, but that halt continuation of the β-sheet, e.g., aminopyrazole derivatives, have been known for some time (1,2). These β-sheet-complementing substa
PAPER Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, Stevens JT, Münch J, Baker D, Eisenberg D
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation.
Nature. 2011 Jul 7;475(7354):96-100. PubMed: 21677644PAPER Fischbeck KH, Pulst SM
Amyotrophic lateral sclerosis and spinocerebellar ataxia 2.
Neurology. 2011 Jun 14;76(24):2050-1. PubMed: 21562249PAPER Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, de Carvalho M, Meyer T, Tysnes OB, Auburger G, Gispert S, Bonini NM, Andersen PM, Gitler AD
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.
Hum Mol Genet. 2011 May 1;20(9):1697-700. PubMed: 21292779PAPER Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
Neurology. 2011 Jun 14;76(24):2066-72. PubMed: 21562247Aaron Gitler on Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.
COMMENT Several recent studies have evaluated the role of ataxin 2 in independent ALS patient populations worldwide and have found an association with polyglutamine repeat expansions and risk for the disease, confirming and extending the initial findings by Nancy
Current Filters
No filters selected